Skip to main content

HAZLETT, BURT & WATSON, INC.

Position in NVO — Novo Nordisk A S

CIK 46392 WHEELING, WV

Position in NVO

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$371,106
+$16,250 QoQ
Shares Held
7,889
-19.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HAZLETT, BURT & WATSON, INC. holds $14,649,393 across 13 Drug Manufacturers - General names. NVO ranks #8 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
7,889 $371,106

All Filings in NVO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $371,106 7,889
2026-03-31 $354,856 9,821
2025-12-31 $541,718 10,709
2025-09-30 $681,408 12,292
2025-06-30 $812,154 11,829
2025-03-31 $710,577 10,313
2024-12-31 $896,068 10,461
2024-09-30 $1,152,591 9,720
2024-06-30 $1,383,148 9,708
2024-03-31 $1,188,475 9,300
2023-12-31 $931,874 9,034
2023-09-30 $501,444 5,540
2023-06-30 $440,014 2,727
2023-03-31 $432,700 2,719
2022-12-31 $367,987 2,719
2022-09-30 $270,891 2,719
2022-06-30 $302,975 2,719
2022-03-31 $321,377 2,894